| Literature DB >> 30224907 |
Anna Lee1, Hyo-Cheol Kim2, Sung Il Hwang3, Ho Jun Chin1, Ki Young Na1, Dong-Wan Chae1, Sejoong Kim1.
Abstract
BACKGROUND: Unenhanced computed tomography (UCT) may be useful for evaluating acute pyelonephritis; however, no study has compared UCT with enhanced computed tomography (ECT) as a diagnostic tool. We evaluated a clinical usefulness of UCT versus ECT in acute pyelonephritis (APN).Entities:
Keywords: Acute Pyelonephritis; Contrast-induced Nephropathy; Parenchymal Involvement; Perinephric Infiltration; Unenhanced Computed Tomography
Mesh:
Year: 2018 PMID: 30224907 PMCID: PMC6137028 DOI: 10.3346/jkms.2018.33.e236
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Fig. 1Study algorithm.
APN = acute pyelonephritis, CT = computed tomography, MM = multiple myeloma, EM = endometrial, MALT = mucosa-associated lymphoid tissue, HCC = hepatocellular carcinoma, UCT = unenhanced computed tomography, ECT = enhanced computed tomography, CIAKI = contrast induced acute kidney injury, VUR = vesicoureteral reflux.
Fig. 2Grade of parenchymal involvement. (A) grade 0: no renal parenchyma involvement, (B) grade 1: less than 25% involvement, (C) grade 2: 25%–50% involvement, (D) grade 3: 50%–75% involvement, (E) grade 4: greater than 75% involvement, and (F) Abcess. Left side present are UCT and right side present are ECT.
UCT = unenhanced computed tomography, ECT = enhanced computed tomography.
Baseline characteristics
| Baseline characteristics (n = 149) | No. (%) of patients | |
|---|---|---|
| Age, yr | 61.2 (19–89) | |
| Sex, male | 31 (21) | |
| Hypertension | 51 (34) | |
| DM | 39 (26.1) | |
| Neurology diseasea | 35 (24.2) | |
| Urology disease | 31 (21) | |
| Neurogenic bladder | 13 (8.7) | |
| Benign prostatic hyperplasia | 10 (6.7) | |
| Othersb | 8 (5.3) | |
| Previous history | 49 (32.8) | |
| APN, UTI | 37 (24.8) | |
| Stone | 12 (8.0) | |
DM = diabetes mellitus, APN = acute pyelonephritis, UTI = urinary tract infection.
aCerebrovascular disease 15 (10), dementia 13 (8.7), Parkinson disease 4 (2.6), Alzheimer's disease 2 (1.3), cerebral palsy 1 (0.6); bOveractive bladder 3 (2.0), foley insertion state 3 (2.0), vesicoureteral reflux 2 (1.3).
Representative CT findings
| Characteristics | No. (%) of patients | |||
|---|---|---|---|---|
| UCT | ECT | |||
| Representative CT | ||||
| Perinephric infiltration | 84 (56) | 85 (57) | ||
| Swelling | 32 (21) | 32 (21) | ||
| Hydronephrosis | 10 (6.7) | 10 (6.7) | ||
| Parenchymal involvement - bilateral involvement | ||||
| 0: no renal parenchyma involvement | 147 (98.6) | 56 (37.5) | ||
| 1: less than 25% involvement | 2 (1.4) | 61 (40.9)–10 (6.7) | ||
| 2: 25% to 50% involvement | 0 (0) | 21 (14)–4 (2.6) | ||
| 3: 50% to 75% involvement | 0 (0) | 6 (4) | ||
| 4: greater than 75% | 0 (0) | 5 (3.3) | ||
| Associated abnormality | ||||
| Cyst | 18 (12) | 28 (18.7) | ||
| Abscess | 0 (0) | 7 (4.6) | ||
| Stone | 28 (18.7) | 25 (16.7) | ||
| Renal | 13 (8.7) | 10 (6.7) | ||
| UPJ | 8 (5.3) | 8 (5.3) | ||
| UVJ | 7 (4.6) | 7 (4.6) | ||
CT = computed tomography, UCT = unenhanced computed tomography, ECT = enhanced computed tomography, UPJ = ureteropelvic junction, UVJ = ureterovesical junction.
Renal abscess
| Abscess size, mm | Female | DM | Hx. of APN, stone, BPH, OAB | Microorganism urine/blood | Sustained fever over 72 hours | Shock |
|---|---|---|---|---|---|---|
| 30 | √ | √ | √ | |||
| 21 | √ | APN | √ | |||
| OAB | ||||||
| 20 | √ | √ | ||||
| 16 | √ | √ | ||||
| 10 | BPH | √ | ||||
| 5 multiple | √ | Stone | ||||
| 5 multiple | √ | APN |
DM = diabetes mellitus, Hx = history, APN = acute pyelonephritis, BPH = benign prostatic hyperplasia, OAB = overactive bladder, ESBL = extended spectrum beta-lactamase, S = same, N = no growth.
Results of blood and urine culture
| Microorganism | No. (%) of patients | |
|---|---|---|
| Bacteriuria | Bacteraemia | |
| 49 (32.8) | 13 (8.7) | |
| 14 (9.3) | 3 (2.0) | |
| 2 (1.3) | 1 (0.6) | |
| 1 (0.6) | 1 (0.6) | |
| 2 (1.3) | 0 | |
| 3 (2.0) | 2 (1.3) | |
| 1 (0.6) | 0 | |
| 1 (0.6) | 0 | |
| Coagulase negative | 2 (1.3) | 1 (0.6) |
| Total | 75 (50.3) | 21 (14.0) |
ESBL = extended spectrum beta-lactamase.